Vaxart's Reverse Merger Round

Vaxart raised a round of funding on October 23, 2012. Investors include Biota Holdings.

Vaxart, formerly Aviragen Therapeutics, Biota Pharmaceuticals, and Nabi Pharmaceuticals, is a clinical-stage company focused on developing oral recombinant protein vaccines based on its proprietary or…

Articles about Vaxart's Reverse Merger Round: